Stay updated on Dapagliflozin in Acute Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.

Latest updates to the Dapagliflozin in Acute Heart Failure Clinical Trial page
- ChecktodayChange DetectedThe study status changed from having no results posted to indicating that results have been submitted. This reflects new progress toward making the trial’s outcome data available to the public.SummaryDifference0.1%

- Check7 days agoChange DetectedRevision label updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.1%

- Check14 days agoNo Change Detected
- Check29 days agoChange DetectedThe page revision was updated to v3.5.0, replacing the previous v3.4.3.SummaryDifference0.1%

- Check43 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3 on the page.SummaryDifference0.1%

- Check50 days agoChange DetectedNo substantive changes detected; core study details appear unchanged.SummaryDifference0.1%

- Check71 days agoChange DetectedAdded a site revision tag (Revision: v3.4.2) and removed older funding-status notices (Revision: v3.4.1). These changes affect only the site metadata and do not modify the study details or eligibility information.SummaryDifference0.5%

Stay in the know with updates to Dapagliflozin in Acute Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin in Acute Heart Failure Clinical Trial page.